ADMA (ADMA Biologics) Short-Term Debt to Capital
The price action of ADMA Biologics (ADMA) reflects the dynamics of a company whose operations rely on the utilization of its own blood collection centers to produce biopharmaceuticals. The current indicator is 0.02. Business efficiency is driven by plant utilization rates, product yield, and the rollout pace of ASCENIV. Meanwhile, the global shortage of immunodeficiency medications provides the firm with immense market leverage and high profitability.
Analytical breakdowns for ADMA Biologics
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital ADMA Biologics|ADMA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio ADMA Biologics, Inc.|ADMA - Aggregate Debt Obligations|Debts to Book Capitalization ADMA Biologics Inc|ADMA - Long-Term Debt Volume|Company Short-Term Debt ADMA Biologics|Quick Liquidity admabiologics.com
Fundamental valuation:ADMA Bio
Inelastic demand for blood plasma-derived medicines provides ADMA Biologics (ADMA) with a stable cash flow, enabling the efficient optimization of its debt structure. An analysis of the current liability-to-equity ratio, specifically the ratio of short-term loans to equity, reveals a trend of fiscal stability, where a systematic reduction in leverage confirms the issuer's strengthening solvency while maintaining optimal tax shields.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital protagonist-inc.com PTGX|IMVT - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Short-Term Debt to Capital|Short-Term Debt to Capital auriniapharma.com|Short-Term Debt to Equity Ratio BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital DNTH (Dianthus Pharma)|Short-Term Debt to Capital Coefficient Pharvaris Pharma (PHVS)|ABCL - Short-Term Debt to Equity|tourmalinebio.com (TRML) - Short-Term Debt to Equity Ratio|Precigen (PGEN) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Pharming Group NV|Short-Term Debt to Equity Ratio NKTR|Short-Term Debt to Capital Upstream Pharma|Short-Term Debt to Equity Zenas Biopharma Inc (ZBIO)|immunome.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Current Liabilities to Capital|Septerna Corp - Short-Term Debt to Capital|PVLA - Short-Term Debt to Capital|SVRA: Short-Term Debt to Capital|Short-Term Debt to Capital Ratio RIGL|Short-Term Debt to Equity AnaptysBio|Short-Term Debt to Equity Ratio Astria Therapeutics Inc (ATXS)|Short-Term Debt to Capital ENGN|Short-Term Debt to Capital rapt.com (RAPT)|Aerovate Therapeutics - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ACRS|Kyverna Therapeutics, Inc. - Short-Term Debt to Capital|TLSA: Short-Term Debt to Equity|CABA: Short-Term Debt to Capital|VTYX - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Theratechnologies Inc.|Current Liabilities to Capital avalotx.com AVTX|Short-Term Debt to Equity Eledon Pharmaceuticals, Inc. (ELDN)|Short-Term Debt to Equity AGEN (Agenus, Inc.)|Short-Term Debt to Equity Climb Bio, Inc. CLYM|zurabio.com (ZURA) - Current Liabilities to Capital|aTyr Pharma, Inc. - Short-Term Debt to Capital|Short-Term Indebtedness to Equity Adagene (ADAG)|IMA: Short-Term Debt to Capital|STTK - Short-Term Debt to Capital Coefficient|EQ (Equillium Inc) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Connect Pharma (CNTB)|Short-Term Debt to Equity Immunic, Inc. (IMUX)|Short-Term Debt to Capital Coefficient atarabio.com|Short-Term Debt to Capital IFRX (InflaRx)|Short-Term Debt to Capital X4 Pharmaceuticals Inc. XFOR|Adicet - Short-Term Debt to Capital|CELU (Celularity Inc.) - Short-Term Debt to Capital Ratio|INmune Bio, Inc. (INMB) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio barinthusbio.com|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital SAB Biotherapeutics Inc.|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|ENLV: Current Liabilities to Equity|Short-Term Debt to Capital QTTB (Q32 Bio)|Ratio of Short-Term Indebtedness to Capital GOVX|Edesa Biotech - Short-Term Debt to Capital|IBIO - Short-Term Debt to Capital|carismatx.com (CARM) - Short-Term Debt to Equity|XTL Bio - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Bolt Biotherapeutics Inc.|Short-Term Debt to Equity Ratio HCW Biologics Inc (HCWB)|Short-Term Debt to Capital APVO|Short-Term Debt to Capital aimimmuno.com (AIM)|Aditxt, Inc. - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital GRI|XORTX Therapeutics Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient reshapelifesciences.com HIND|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Indaptus Therapeutics Inc|Short-Term Debt to Equity Scinai|Short-Term Debt to Equity Ratio CalciMedica Corp (CALI)|Short-Term Debt to Equity Ratio AFMD (Affimed)|Short-Term Debt to Capital allakos.com (ALLK)|Short-Term Debt to Equity HOOKIPA Pharma HOOK|IGMS: Short-Term Debt to Capital Ratio|iTeos - Short-Term Debt to Capital|Current Liabilities to Capital Ocean Biomedical Corp|TCBP: Short-Term Debt to Capital|thirdharmonicbio.com (THRD) - Short-Term Debt to Capital